These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34028110)

  • 1. Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
    Visseren T; Erler NS; Polak WG; Adam R; Karam V; Vondran FWR; Ericzon BG; Thorburn D; IJzermans JNM; Paul A; van der Heide F; Taimr P; Nemec P; Pirenne J; Romagnoli R; Metselaar HJ; Darwish Murad S;
    Transpl Int; 2021 Aug; 34(8):1455-1467. PubMed ID: 34028110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
    Ravikumar R; Tsochatzis E; Jose S; Allison M; Athale A; Creamer F; Gunson B; Iyer V; Madanur M; Manas D; Monaco A; Mirza D; Owen N; Roberts K; Sen G; Srinivasan P; Wigmore S; Fusai G; Fernando B; Burroughs A
    J Hepatol; 2015 Nov; 63(5):1139-46. PubMed ID: 26186988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.
    Venkat VL; Ranganathan S; Mazariegos GV; Sun Q; Sindhi R
    Liver Transpl; 2014 Jun; 20(6):679-86. PubMed ID: 24634351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study.
    Visseren T; Erler NS; Heimbach JK; Eaton JE; Selzner N; Gulamhusein A; van der Heide F; Porte RJ; van Hoek B; Alwayn IPJ; Metselaar HJ; IJzermans JNM; Darwish Murad S
    JHEP Rep; 2022 Dec; 4(12):100599. PubMed ID: 36426376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.
    Lindström L; Jørgensen KK; Boberg KM; Castedal M; Rasmussen A; Rostved AA; Isoniemi H; Bottai M; Bergquist A
    Scand J Gastroenterol; 2018 Mar; 53(3):297-304. PubMed ID: 29301479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study.
    Martinez M; Perito ER; Valentino P; Mack CL; Aumar M; Broderick A; Draijer LG; Fagundes EDT; Furuya KN; Gupta N; Horslen S; Jonas MM; Kamath BM; Kerkar N; Kim KM; Kolho KL; Koot BGP; Laborda TJ; Lee CK; Loomes KM; Miloh T; Mogul D; Mohammed S; Ovchinsky N; Rao G; Ricciuto A; Rodrigues Ferreira A; Schwarz KB; Smolka V; Tanaka A; Tessier MEM; Venkat VL; Vitola BE; Woynarowski M; Zerofsky M; Deneau MR
    Hepatology; 2021 Oct; 74(4):2047-2057. PubMed ID: 34008252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.
    Brandsaeter B; Schrumpf E; Bentdal O; Brabrand K; Smith HJ; Abildgaard A; Clausen OP; Bjoro K
    Liver Transpl; 2005 Nov; 11(11):1361-9. PubMed ID: 16184522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
    Alabraba E; Nightingale P; Gunson B; Hubscher S; Olliff S; Mirza D; Neuberger J
    Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience.
    Moncrief KJ; Savu A; Ma MM; Bain VG; Wong WW; Tandon P
    Can J Gastroenterol; 2010 Jan; 24(1):40-6. PubMed ID: 20186355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with
    Bajer L; Slavcev A; Macinga P; Sticova E; Brezina J; Roder M; Janousek R; Trunecka P; Spicak J; Drastich P
    World J Gastroenterol; 2018 Nov; 24(43):4939-4949. PubMed ID: 30487703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-Transplant Disease Recurrence in Pediatric PSC.
    Soufi N; Bazerbachi F; Deneau M
    Curr Gastroenterol Rep; 2018 Aug; 20(9):44. PubMed ID: 30083892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis - a propensity score-matched intention-to-treat analysis.
    Åberg F; Sallinen V; Tuominen S; Adam R; Karam V; Mirza D; Heneghan MA; Line PD; Bennet W; Ericzon BG; Grat M; Lodge P; Rasmussen A; Schmelzle M; Thorburn D; Fondevila C; Helanterä I; Nordin A;
    J Hepatol; 2024 Jan; 80(1):99-108. PubMed ID: 37722533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis.
    Martin EF; Levy C
    Semin Liver Dis; 2017 Nov; 37(4):305-313. PubMed ID: 29272893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
    Steenstraten IC; Sebib Korkmaz K; Trivedi PJ; Inderson A; van Hoek B; Rodriguez Girondo MDM; Maljaars PWJ
    Aliment Pharmacol Ther; 2019 Mar; 49(6):636-643. PubMed ID: 30740723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis.
    Mammadov RA; Selten JW; Roest HP; Verhoeven CJ; Maroni L; Bril SI; Tolenaars D; Gadjradj PS; van de Graaf SFJ; Oude Elferink RPJ; Kwekkeboom J; Metselaar HJ; Peppelenbosch MP; Beuers U; IJzermans JNM; van der Laan LJW
    Transplantation; 2023 Aug; 107(8):1764-1775. PubMed ID: 36978227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.
    Visseren T; Darwish Murad S
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):187-198. PubMed ID: 28624107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data.
    Catanzaro E; Gringeri E; Cazzagon N; Floreani A; Cillo U; Burra P; Gambato M
    J Pers Med; 2024 Feb; 14(3):. PubMed ID: 38540965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.